FDA Uloric Warning Renews Concerns over Older Gout Drug Allopurinol
Terry Turner, Drugwatch The number of people taking the gout medication allopurinol has been rising as gout becomes more prevalent. Prescriptions also got a boost after the U.S. Food and Drug Administration limited the use of Uloric (febuxostat) in 2019, effectively leaving allopurinol as the primary first-line medication option for gout patients. But at the […]